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Essential universal health coverage needs local capacity 
development
Disease Control Priorities, 3rd edition (DCP3), published 
in 2017, reanimated academic debate about the value 
of cost-effectiveness and global knowledge in priority 
setting for national health policy.1 In 1993, the first 
DCP project was published by Jamison and his team2 
with the support of the World Bank, which was part 
of a larger project by the World Bank to define health 
as an investment rather than an expenditure at the 
international and national levels.3 DCP1 and DCP2, 
which was published in 2006, both substantially 
influenced the ways in which the World Bank, WHO, 
and other global health donors prioritised investment 
in health interventions in low-income countries (LICs) 
and lower-middle-income countries (lower-MICs), but 
they had insufficient uptake by the governments in 
these countries.4 This lack of uptake was partly due, as 
critics of DCP1 and DCP2 argued, to an overemphasis 
on the economic evaluation of health interventions 
over other important factors, including health equity.5 
Furthermore, insufficient attention was given to the 
technical capacity required to interpret DCP data and 
translate it into local health policy.6
In response to these critiques, and to update the 
DCP in alignment with the Sustainable Development 
Goals, DCP3 was produced with the aim that it would 
be most useful for ministers of finance in LICs and 
lower-MICs. Although DCP3 does expand beyond 
cost-effectiveness to include other objectives such as 
financial protection, palliative care, and contraception 
needs,1 the report prompted further reflection on the 
role of economic evaluation in health policy making. 
As the field of health economics has expanded in the 
past few decades, rapid advances in the development 
of health economic tools have paradoxically made such 
tools less useful for decision makers.7 Therefore, future 
versions of the DCP should emphasise health-care 
needs at the national and local levels, and highlight 
the importance of country-level technical capacity to 
understand these needs.6 This strengthened technical 
capacity to interpret and contextualise DCP evidence 
at the country level should also be paired with 
reporting and use of direct mortality data rather than 
modelled data.8
In this context, David Watkins and colleagues9 have 
produced a modelling study and an online costing tool—
the Disease Control Priorities Cost Model (DCP-CM)—
as starting points to help countries prioritise their 
health packages and achieve what the authors 
of DCP3 term essential universal health coverage 
(EUHC). The team has produced cost estimates for the 
218 health interventions that comprise the 21 packages 
of EUHC, and for the 112 interventions within these 
that comprise a highest priority package in DCP3. The 
cost estimates are for two stylised countries standing 
in for LICs and lower-MICs, using the World Bank criteria 
to define these income groups.
Their study and the online costing tool are invaluable 
for health financing advocacy—both make clear 
the need for increased domestic and global financial 
resources, via modelling the cost of implementing even 
minimum versions of UHC for countries in the midst 
of epidemiological transition. Furthermore, DCP-CM 
undoubtedly provides an important starting point for 
ministers of finance and health to build budgets for robust 
national health systems. However, as tools for prioritising 
interventions in national health policy, this study and the 
DCP-CM should be accompanied by extensive country-
level expertise on actual costs of health interventions 
and local data on disease burden, alongside other, non-
economic forms of evaluation. They provide a reminder of 
the importance of investing in local capacity devzzzelop-
ment beyond short-term engagement or knowledge 
produced in a global context. As many researchers 
have reiterated,4–8 building health policy for UHC in LICs 
and lower-MICs should attend not only to economic 
evaluation, but also to local values and contexts, the 
issue of health equity, and investment in local capacity 
development.
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